Rivian Releases Q2 2025 Production and Delivery Figures, Announces Funding of $1B Volkswagen Group Investment in Rivian and Sets Date for Second Quarter 2025 Financial Results
Production and delivery results for the quarter are in line with Rivian's outlook. Rivian is also reaffirming its 2025 delivery guidance range of 40,000 to 46,000 vehicles.
Following its second quarter of gross profit in Q1 2025, on June 30 Rivian received a $1 billion equity investment from Volkswagen Group at an effective price of $19.42 which represents a 33% premium to the $14.56 30-trading day volume-weighted average stock price. The investment is part of the $5.8 billion agreement associated with the Rivian and Volkswagen Group technology joint venture.
The company also announced that on August 5th, 2025 after market close, it will release its second quarter 2025 financial results. Rivian will host an audio webcast at 5:00 p.m. ET the same day to discuss the performance and outlook for the business. The live webcast will be available at https://rivian-q2-earnings-webcast-2025.open-exchange.net/ and a replay will be available for four weeks at www.rivian.com/investors following the webcast.
Forward-Looking Statements:
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including without limitation statements regarding our annual delivery outlook.
We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our business, financial condition, and results of operations. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance, or achievements to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements, including, but not limited to, the important factors discussed in Part II, Item 1A, 'Risk Factors' in our Quarterly Report on Form 10-Q for the quarter ended March 31, 2025, and our other filings with the Securities and Exchange Commission. The forward-looking statements in this press release are based upon information available to us as of the date of this press release, and while we believe such information forms a reasonable basis for such statements, such information may be limited or incomplete, and our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain, and investors are cautioned not to unduly rely upon these statements. While we may elect to update such forward-looking statements at some point in the future, we disclaim any obligation to do so, even if subsequent events cause our views to change.
About Rivian:
Rivian (NASDAQ: RIVN) is an American automotive manufacturer that develops and builds category-defining electric vehicles as well as software and services that address the entire lifecycle of the vehicle. The company creates innovative and technologically advanced products that are designed to excel at work and play with the goal of accelerating the global transition to zero-emission transportation and energy. Rivian vehicles are built in the United States and are sold directly to customers in the consumer and commercial markets. Whether taking families on new adventures or electrifying fleets at scale, Rivian vehicles all share a common goal — preserving the natural world for generations to come.
Learn more about the company, products, and careers at www.rivian.com.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
14 minutes ago
- Yahoo
Monte Rosa Announces Publication in Science of Key Insights that Enable Next Generation Molecular Glue Degrader Medicines
Monte Rosa's AI/ML-powered insights dramatically increase targetable protein space for molecular glue degraders, unlocking new opportunities to address previously undruggable therapeutic targets Science, 3 July 2025 BOSTON, July 03, 2025 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics, Inc. (Nasdaq: GLUE), a clinical-stage biotechnology company developing novel molecular glue degrader (MGD)-based medicines, today announced the publication of groundbreaking new discoveries featured on the cover of Science. The research article, 'Mining the CRBN Target Space Redefines Rules for Molecular Glue-induced Neosubstrate Recognition,' details how Monte Rosa's proprietary artificial intelligence (AI) and machine learning (ML) engine has uncovered a broad range of human proteins potentially accessible to cereblon (CRBN)-based degradation, spanning diverse protein domains and classes. These findings dramatically expand the actionable target space for MGD drug discovery. 'The findings from this landmark publication, featured on the cover of Science, have accelerated our ability to develop first-in-class medicines for historically intractable targets, validating the power of our QuEEN™ discovery engine to create the next generation of molecular glue degrader medicines,' said Sharon Townson, Ph.D., Chief Scientific Officer of Monte Rosa. 'We're already leveraging these insights to advance our growing pipeline of differentiated MGDs and future medicines that have the potential to transform patients' lives.' 'Our cutting-edge approach to MGD discovery integrates internal datasets with geometric deep learning to characterize protein surfaces. We have uncovered new rules of engagement between protein targets, small molecules and E3 ligases such as cereblon that we're actively exploiting via our proprietary QuEEN discovery engine to rationally design exquisitely selective degrader therapies,' said John Castle, Ph.D., Chief Data and Information Officer at Monte Rosa. 'This work not only highlights the flexibility of cereblon but also demonstrates our ability to design MGDs that address previously inaccessible, disease-relevant proteins.' Monte Rosa's QuEEN discovery engine uses custom-built AI/ML algorithms to analyze protein surfaces at unprecedented scale, identifying previously unrecognized surfaces capable of recruiting cereblon for targeted protein degradation. The novel surface features greatly expand the reach of MGDs and redefine the requirements that govern molecular glue-induced target engagement. The paper further details Monte Rosa's proprietary AI and ML approaches that enabled these discoveries, incorporating geometric deep learning to encode protein surface patches and project geometrical features across the proteome to identify complementary structures that can mediate protein-protein interactions. The analysis successfully identified new protein targets amenable to Monte Rosa's drug discovery approach, spanning more than 100 target classes, many of which are currently considered to be inaccessible to small molecule binding. The findings significantly broaden Monte Rosa's potential therapeutic reach in areas including immunology, inflammation and oncology, where the company is currently advancing programs in the clinic. About Monte RosaMonte Rosa Therapeutics is a clinical-stage biotechnology company developing highly selective molecular glue degrader (MGD) medicines for patients living with serious diseases in the areas of oncology, autoimmune and inflammatory diseases, and more. MGDs are small molecule protein degraders that have the potential to treat many diseases that other modalities, including other degraders, cannot. Monte Rosa's QuEEN™ (Quantitative and Engineered Elimination of Neosubstrates) discovery engine combines AI-guided chemistry, diverse chemical libraries, structural biology, and proteomics to rationally design MGDs with unprecedented selectivity. Monte Rosa has developed the industry's leading pipeline of MGDs, which spans autoimmune and inflammatory diseases, oncology, and beyond. Monte Rosa has a global license agreement with Novartis to advance VAV1-directed molecular glue degraders and a strategic collaboration with Roche to discover and develop MGDs against targets in cancer and neurological diseases previously considered impossible to drug. For more information, visit InvestorsAndrew Funderburk ir@ MediaCory Tromblee, Scient PRmedia@ A photo accompanying this announcement is available at in to access your portfolio
Business Wire
15 minutes ago
- Business Wire
Liberty Energy Inc. Announces Timing of Release of Second Quarter 2025 Financial Results and Conference Call
DENVER--(BUSINESS WIRE)--Liberty Energy Inc. (NYSE: LBRT) announced today that it will release its financial results for the second quarter ending June 30, 2025, after the market closes on Wednesday, July 23, 2025. Following the release, the Company will host a conference call to discuss the results at 8:00 a.m. Mountain Time (10:00 a.m. Eastern Time) on Thursday, July 24, 2025. Presenting the Company's results will be Ron Gusek, President and Chief Executive Officer, and Michael Stock, Chief Financial Officer. Individuals wishing to participate in the conference call should dial (833) 255-2827, or for international callers, (412) 902-6704. Participants should ask to join the Liberty Energy call. A live webcast will be available at The webcast can be accessed for 90 days following the call. A telephone replay will be available shortly after the call and can be accessed by dialing (877) 344-7529, or for international callers (412) 317-0088. The passcode for the replay is 7843160. The replay will be available until July 31, 2025. About Liberty Liberty Energy Inc. (NYSE: LBRT) is a leading energy services company. Liberty is one of the largest providers of completion services and technologies to onshore oil, natural gas, and enhanced geothermal energy producers in North America. Liberty also owns and operates Liberty Power Innovations LLC, providing advanced distributed power and energy storage solutions for the commercial and industrial, data center, energy, and mining industries. Liberty was founded in 2011 with a relentless focus on value creation through a culture of innovation and excellence and the development of next generation technology. Liberty is headquartered in Denver, Colorado. For more information, please visit and or contact Investor Relations at IR@
Yahoo
22 minutes ago
- Yahoo
AM Best Affirms Credit Ratings of Worldwide Reinsurance Limited
MEXICO CITY, July 03, 2025--(BUSINESS WIRE)--AM Best has affirmed the Financial Strength Rating of B+ (Good) and the Long-Term Issuer Credit Rating of "bbb-" (Good) of Worldwide Reinsurance Limited (Worldwide Re) (Trinidad and Tobago). The outlook of these Credit Ratings (ratings) is positive. The ratings reflect Worldwide Re's balance sheet strength, which AM Best assesses as strong, as well as its adequate operating performance, neutral business profile and marginal enterprise risk management (ERM). The positive outlooks reflect Worldwide Re's improvements to its ERM profile through enhancements to its non-proportional retrocession structure and further reinforcement of its corporate governance, which safeguards its strongest risk-adjusted capitalization supportive of a stable balance sheet strength, and sound operating performance. Worldwide Re launched operations in 2013, to provide reinsurance capacity for property, marine and liability lines of business and is diversified geographically throughout Europe, where the majority of its business is currently located, Oceania, Asia, Central America, South America and the Caribbean. Worldwide Re operates through a network of brokers, intermediaries and managing general agents. The ratings also reflect Worldwide Re's good and sustained underwriting quality and profitability, solid capital management and geographically diversified premiums. Partially offsetting these positive rating factors are the highly competitive landscape in its target geographic markets amid a challenging economic environment. The company's capital base has grown consistently over time through reinvestment of earnings, reflecting a compound annual growth rate of 10.5% as of 2024, mainly driven by sound underwriting practices. In 2024, Worldwide Re recorded a combined ratio of 72.7% and a return on equity of 31.4%, enabled by a surge in its growth and well-contained overall expenses, as well as a release of excess reserves. Additionally, AM Best expects future acquisition expenses to offset deviations in claims as the company decreases its risk retention, while expanding consistently in target geographies, along with a good reinsurance security panel. Financial income continues to support Worldwide Re's results; however, the company is not dependent on this revenue to achieve positive bottom-line results. Worldwide Re constantly reviews its underwriting guidelines to improve the performance of its business segments that are deviating from targets. Positive rating actions could occur if the company is able to maintain improvements in its ERM profile, while maintaining its current level of risk-adjusted capitalization supporting a stable balance sheet. Negative rating actions could occur if the company's operating performance deteriorates to a level no longer supportive of the ratings. This press release relates to Credit Ratings that have been published on AM Best's website. For all rating information relating to the release and pertinent disclosures, including details of the office responsible for issuing each of the individual ratings referenced in this release, please see AM Best's Recent Rating Activity web page. For additional information regarding the use and limitations of Credit Rating opinions, please view Guide to Best's Credit Ratings. For information on the proper use of Best's Credit Ratings, Best's Performance Assessments, Best's Preliminary Credit Assessments and AM Best press releases, please view Guide to Proper Use of Best's Ratings & Assessments. AM Best is a global credit rating agency, news publisher and data analytics provider specializing in the insurance industry. Headquartered in the United States, the company does business in over 100 countries with regional offices in London, Amsterdam, Dubai, Hong Kong, Singapore and Mexico City. For more information, visit Copyright © 2025 by A.M. Best Rating Services, Inc. and/or its affiliates. ALL RIGHTS RESERVED. View source version on Contacts Salvador Smith, CQF Associate Director, Analytics +52 55 9085 7506 Alfonso Novelo Senior Director, Analytics +52 55 9085 7501 Christopher Sharkey Associate Director, Public Relations +1 908 882 2310 Al Slavin Senior Public Relations Specialist +1 908 882 2318 Sign in to access your portfolio
